![Comprehensive molecular profiles of the most common cancer types are now available. [NHGRI]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/74.jpeg "Comprehensive molecular profiles of the most common cancer types are now available. [NHGRI]")
As you have probably noticed, there’s been a major shift in the focus of next-gen sequencing over the past couple of years. First it was all about new genomes, new techniques, and discovery. Now it’s all about translation. We are entering a new era in next-gen sequencing, one in which NGS technologies will not only be used for discovery, but will be integrated into clinical care.
A review in the latest issue of Human Molecular Genetics discusses NGS-enabled cancer genomics from the clinician’s point of view. In it, the authors highlight recent findings from large-scale cancer genomics efforts—such as the Cancer Genome Atlas—and offer their perspectives on the significant challenge facing us: translating the knowledge from such massive “oncogenomic” datasets to the clinic.
For the rest of the story, click here.
